Cargando…
Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling
Although past studies observed the changes of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in end-stage heart failure (HF) patients, a consistent and clear pattern of type-specific MMPs and/or TIMPs has yet to be further defined. In this study, proteomic appro...
Autores principales: | Wei, Yingjie, Cui, Chuanjue, Lainscak, Mitja, Zhang, Xiaoling, Li, Jun, Huang, Jie, Zhang, Hao, Zheng, Zhe, Hu, Shengshou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922666/ https://www.ncbi.nlm.nih.gov/pubmed/20219015 http://dx.doi.org/10.1111/j.1582-4934.2010.01049.x |
Ejemplares similares
-
Elevation of IGF-2 receptor and the possible underlying implications in end-stage heart failure patients before and after heart transplantation
por: Wei, Yingjie, et al.
Publicado: (2012) -
Enhanced Expression but Decreased Specific Activity of Matrix Metalloproteinase 10 (MMP-10) in Comparison with Matrix Metalloproteinase 3 (MMP-3) in Human Urinary Bladder Carcinoma
por: Kudelski, Jacek, et al.
Publicado: (2021) -
Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
por: Hur, J. H., et al.
Publicado: (2000) -
Expression and function of matrix metalloproteinase (MMP)-28
por: Rodgers, Ursula R., et al.
Publicado: (2009) -
Quantification of matrix metalloproteinases MMP-8 and MMP-9 in gingival overgrowth
por: Orozco-Páez, Jennifer, et al.
Publicado: (2021)